Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: L-TIL
Total 3 results
Quanli Gao
Recruiting
L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC
Non-small Cell Lung Cancer
China
Quanli Gao
Not yet recruiting
L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma
Malignant Melanoma
Henan Cancer Hospital
Unknown
L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy
Advanced Solid Tumor
China
Sponsors and Collaborators
Gerhard Treiber
Innoventus Project AB
Dell'Angelo Hospital, Mestre-Venice, Italy
Novartis Healthcare A/S
Merck Frosst-Schering Pharma, G.P.
East Tennessee State University, College of Public Health, Department of Health Sciences
Cardiora Pty. Ltd.
WUHAN NO.7 HOSPITAL
Hayandra Peduli Foundation
TYRX, Inc.
The Michaelsen Foundation
Medtronic Australasia
Swiss Chiropractic Patient Association (Pro Chiropractic Switzerland)
Norra Alvsborgs Lans Hospital, Trollhattan
Spectrum Pharmaceuticals, Inc
Angela Kashuba, PharmD
University of Reims Champagne-Ardenne (Ali Oker PhD)
Nicolas C. Buchs
Margaret Mueller
Mostafa Bahaa
View Full List
Medical Conditions
The Safety of Lactobacillus Salivarius
Spinocerebellar Ataxia 30
Radial Scar
Urticaria Chronic
Dislocated Intraocular Lens Into Vitreous
Work Related Musculoskeletal Disorders
Cytomegalovirus Infections
Vaginal Examination
Ancylostoma Caninum
CML (Chronic Myelogenous Leukemia)
Pain, Postoperative/Prevention & Control
LAPAROSCOPY
AHUS
Metaphyseal Fracture of Bone of Upper Limb
Persistent or Permanent Non-valvular Atrial Fibrillation
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
TP53
Evidence of Cardiovascular Morbidity
Cerebrospinal; Disorder
Tone Increased, Muscle
View Full List
Drug Interventions
Paclitaxel + Carboplatin
IDEAL-E observation (investigators choice of imatinib, nilotinib, dasatinib, radotinib)
Sotrovimab
NNC 0070-0002-0349
Pantoprazole
Enoxaparin
Mirvetuximab Soravtansine (IMGN853)
CP-675,206
Trifluridine
Indocyanine green
INCB057643
Clomiphene citrate
Paclitaxel
[123] 5-I-A-85380
PH797804
Docetaxel
Ralimetinib (LY2228820 dimesylate)
Lu AF95245 14C radiolabelled spiked dosage
Pemetrexed
Norvasc
View Full List
CROs by country
Contract Research Organizations in Czech Republic
Contract Research Organizations in Egypt
Contract Research Organizations in Gabon
Contract Research Organizations in Greece
Contract Research Organizations in Hungary
Contract Research Organizations in Jordan
Contract Research Organizations in Liberia
Contract Research Organizations in Nigeria
Contract Research Organizations in Panama
Contract Research Organizations in Paraguay
Contract Research Organizations in Rwanda
Contract Research Organizations in Switzerland
Contract Research Organizations in Thailand
CRO list by country
CROs in Cyprus
ZEINCRO
Coronis Research SA
ClinBay
EastHORN Clinical Services
All CROs in Cyprus
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe